Key facts
- This page summarizes Henry Brem's Form 4 filing for GALECTIN THERAPEUTICS INC (GALT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Mar 2026, 09:46.
Henry Brem - 12 Mar 2026 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)
- Reporting relationship
- Director
- Issuer ticker
- GALT
- Reported as of
- 12 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- Jack W. Callicutt, by power of attorney
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Henry Brem filed Form 4 for GALECTIN THERAPEUTICS INC (GALT) on 17 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001387877
Primary reporting owner
Brem Henry
- Relationship
- Director
- Address
- 4960 PEACHTREE INDUSTRIAL BLVD, SUITE 240, NORCROSS
- Signature
- Jack W. Callicutt, by power of attorney
- Signature date
- 17 Mar 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GALT
transaction
Derivative
Stock option (right to buy)
Award
- Transaction value
- Shares
- +60,000
- Change %
- Price
- $0.000000*
- Shares after
- 60,000
- Date
- 12 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,000
- Exercise price
- $3.16
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
Footnote F2
The options vest 100% on December 31, 2026.